The Role of Prevention in the Management of Atherosclerotic Disease and Aortic Stenosis

Author(s):

Experts discuss the clinical and economic burden of atherosclerotic cardiovascular disease (ASCVD) and aortic stenosis in the US, exploring their impact on health care systems, the importance of prevention in reducing this burden, and the challenges of implementing preventive strategies, while considering the potential benefits of improved risk assessment and prevention in the ASCVD space.

EP: 1.Lp(a) in ASCVD and Guideline Recommendations

EP: 2.Introduction and Burden of Atherosclerotic Disease and Aortic Stenosis

Now Viewing

EP: 3.The Role of Prevention in the Management of Atherosclerotic Disease and Aortic Stenosis

Video content above is prompted by the following:

Please describe the clinical and economic burden of atherosclerotic cardiovascular disease—or ASCVD—and aortic stenosis in the US today.
How do these diseases impact health systems like the ones you work with?
What role does prevention play in mitigating this burden?
Adherence to preventive regimens can be difficult for patients. On a population level, do the challenges of implementing preventive ASCVD strategies outweigh the benefits? Is there a place for better risk assessment and prevention in the ASCVD space?